Relief Therapeutics Holding AG (RLFTF)

[Bill B]

I hope their fate doesn't befall us. You would expect Javitt would design a suitable study since he was FDA but I recall he was tap dancing around the data because some hospitals were overrun with patients and couldn't carry out the study effectively. On the face of it his point makes complete sense but the only opinion is that of the FDA. Fingers crossed.

Oh, by the way. The FDA just ended cydy. Brutal.